Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.  Lenoir C, Niederer A, Rollason V, Desmeules JA, Daali Y, Samer CF.  CPT Pharmacometrics Syst…

Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions Shamema Nasrin, Christy J.W. Watson, Yadira X Perez-Paramo and Philip Lazarus Drug Metabolism and Disposition December 2021, 49…

Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites Shamema Nasrin, Christy J. W. Watson, Keti Bardhi, Gabriela Fort, Gang Chen and Philip Lazarus Drug Metabolism and Disposition December 2021, 49 (12) 108…

Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study.  Bart G, Giang LM, Yen H, Hodges JS, Brundage RC.  Drug Alcohol Depend. 2021 Oct 1;227:109025…

Evaluation of drug-drug interactions in hospitalized patients on medications for OUD.  Berger O, Rector K, Meredith J, Sebaaly J.  Ment Health Clin. 2021 Jul 16;11(4):231-237. doi: 10.9740/mhc.2021.07.231. PMID: 34316418; PMCID: PMC82878…

Adverse drug reactions with naltrexone: Experience from an addiction treatment center.  Sarkar S, Addagadda SS, Bhatia G, Chadda RK.  Indian J Psychiatry. 2021 Mar-Apr;63(2):206-207. doi: 10.4103/psychiatry.IndianJPsychiatry_94_20. Epub…